Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medicalgorithmics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Medicalgorithmics

Medicalgorithmics

Public

Medicalgorithmics: Global leader in cardiac monitoring solutions, innovating with mobile ECG technology.

HQ
New York City, NY, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Medicalgorithmics is a global leader in cardiac monitoring solutions, specializing in non-invasive mobile ECG and arrhythmia diagnostic technology. Their flagship product, PocketECG, provides continuous, real-time heart monitoring, catering to patients and healthcare providers worldwide. The company focuses on advancing cardiac care through innovative technology, aiming to improve patient outcomes and streamline diagnostic processes.

Medicalgorithmics has achieved significant milestones, including receiving CE certification for their next-generation AI algorithms, DeepRhythmAI. The company is publicly traded on the sWIG80 index and has demonstrated a robust business model and strategy. Notable figures include Przemysław A. Schmidt and Marzena Piszczek, who were recently appointed to the supervisory board, further strengthening the company's leadership.

Medicalgorithmics - Similar Companies

AliveCor logo

AliveCor

alivecor.com

Cardiac Insight logo

Cardiac Insight

AccurKardia logo

AccurKardia

accurkardia.com

SafeBeat logo

SafeBeat

safebeat.com

VivaQuant logo

VivaQuant

vivaquant.com

Cardiodiagnostics logo

Cardiodiagnostics

Anumana logo

Anumana

anumana.net

iRhythm logo

iRhythm

irhythmtech.com

Eko Health logo

Eko Health

ekohealth.com

ACS Diagnostics logo

ACS Diagnostics

acsd4u.com

QT Medical logo

QT Medical

qtmedical.com

Pace mate logo

Pace mate

pacemate.com

Cardiox logo

Cardiox

cardiox.com

Heartio logo

Heartio

heartio.ai

RhythmScience logo

RhythmScience

Medicalgorithmics - Quick Facts

Who are Medicalgorithmics' competitors?

Companies similar to Medicalgorithmics include AliveCor, Cardiac Insight, AccurKardia and SafeBeat.

When was Medicalgorithmics founded?

Medicalgorithmics was founded in 2005.

Where is Medicalgorithmics' headquarters located?

Medicalgorithmics' headquarters is located in New York City, NY, US.

When was Medicalgorithmics' last funding round?

Medicalgorithmics' most recent funding round was for $2M (USD) in January 2007.

How much has Medicalgorithmics raised to-date?

As of Jan 1, 2007, Medicalgorithmics has raised a total of $2M (USD).

How many employees does Medicalgorithmics have?

Medicalgorithmics has 175 employees as of Feb 4, 2024.

Medicalgorithmics - Classification

Ownership
  • Public
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cardiac Monitoring
  • ECG
Tags
  • Data
  • Healthcare
  • Healthtech
  • Medical Devices
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified